These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17587702)

  • 1. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan.
    Yamazaki T; Goto S; Shigematsu H; Shimada K; Uchiyama S; Nagai R; Yamada N; Matsumoto M; Origasa H; Bhatt DL; Steg PG; Ikeda Y;
    Circ J; 2007 Jul; 71(7):995-1003. PubMed ID: 17587702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.
    Bhatt DL; Steg PG; Ohman EM; Hirsch AT; Ikeda Y; Mas JL; Goto S; Liau CS; Richard AJ; Röther J; Wilson PW;
    JAMA; 2006 Jan; 295(2):180-9. PubMed ID: 16403930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH Registry.
    Gaxiola E; Eng-Ceceña L; Ortiz-Galván F; Llamas-López L; Rangel-Guerra R; Alcocer-Gamba MA; Bhatt DL; Gabriel Steg P;
    Clin Cardiol; 2010 Jul; 33(7):445-51. PubMed ID: 20641123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factor control and treatment of atherothrombosis. Spain REACH Registry].
    Suárez C; Cairols M; Castillo J; Esmatjes E; Sala J; Llobet X; Palma JC;
    Med Clin (Barc); 2007 Oct; 129(12):446-50. PubMed ID: 17953908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of atherothrombotic risk factors in high-risk Canadian outpatients.
    Bell A; Hill MD; Herman RJ; Girard M; Cohen E;
    Can J Cardiol; 2009 Jun; 25(6):345-51. PubMed ID: 19536375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
    J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
    Mahoney EM; Wang K; Cohen DJ; Hirsch AT; Alberts MJ; Eagle K; Mosse F; Jackson JD; Steg PG; Bhatt DL;
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):38-45. PubMed ID: 20031786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
    Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
    Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
    J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: insight from the REACH Registry.
    Yeo TC; Chan YH; Low LP; Venketasubramanian N; Lim SC; Tay JC; Tan RS; Eng P; Lingamanaicker J;
    Ann Acad Med Singap; 2008 May; 37(5):365-71. PubMed ID: 18536821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.
    Alberts MJ; Bhatt DL; Mas JL; Ohman EM; Hirsch AT; Röther J; Salette G; Goto S; Smith SC; Liau CS; Wilson PW; Steg PG;
    Eur Heart J; 2009 Oct; 30(19):2318-26. PubMed ID: 19720633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe.
    Morrell J; Zeymer U; Baumgartner I; Limbourg T; Röther J; Bhatt DL; Steg PG;
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):270-7. PubMed ID: 20606595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.
    Smolderen KG; Bell A; Lei Y; Cohen EA; Steg PG; Bhatt DL; Mahoney EM;
    Can J Cardiol; 2010 Oct; 26(8):297-305. PubMed ID: 20931098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underrecognition and undertreatment of atherothrombotic diseases: REACH Registry Taiwan baseline data.
    Cheng TJ; Hsieh YK; Ryu SJ; Lai WT; Lo HM; Sung ML; Tsao WL; Yip PK; Liau CS;
    J Formos Med Assoc; 2007 Jul; 106(7):548-57. PubMed ID: 17660144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.
    Ruff CT; Bhatt DL; Steg PG; Gersh BJ; Alberts MJ; Hoffman EB; Ohman EM; Eagle KA; Lip GY; Goto S;
    Int J Cardiol; 2014 Jan; 170(3):413-8. PubMed ID: 24321327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
    Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
    JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.
    Udell JA; Steg PG; Scirica BM; Eagle KA; Ohman EM; Goto S; Alsheikh-Ali AA; Porath A; Corbalan R; Umez-Eronini AA; Hoffman EB; Wilson PW; Bhatt DL;
    Eur J Prev Cardiol; 2014 Dec; 21(12):1531-40. PubMed ID: 23918840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
    Boden WE; Cherr GS; Eagle KA; Cannon CP; Califf RM; Hirsch AT; Alberts MJ; Criqui M; Creager MA; Massaro JM; D'Agostino RB; Steg PG; Bhatt DL;
    Crit Pathw Cardiol; 2010 Sep; 9(3):116-25. PubMed ID: 20802264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterising atherothrombosis in Hong Kong: results of the Hong Kong data from a global atherothrombosis epidemiological survey.
    Tsang MW; Chu CL; Kam YW; Kwong KH; Lam CK; Ngan SY; Yu YK
    Hong Kong Med J; 2005 Feb; 11(1):36-41. PubMed ID: 15687514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.